CD366 (TIM-3) Antibody, anti-mouse, REAlease®
Synonyms: Tim3, CD366
RECOMBINANT
Clone:
REAL168
Type of antibody:
Releasable antibodies, Primary antibodies, Recombinant antibodies
Applications:
FC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a size:
Other sizes

Related products for CD366 (TIM-3) Antibody, anti-mouse, REAlease®

Flow cytometry applications
APC
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-115-178, 130-122-623
Description:
Splenocytes from C57BL6 mice were stained with REAlease CD366 (TIM-3)-APC (B) or with the corresponding REAL Control (A). REAlease CD366 (TIM-3)-APC was released using the REAlease Release Reagent (C). To show epitope accessibility after REAlease Complex release, the cells were washed with the REAlease Stop Reagent and restained with REAlease CD366 (TIM-3)-APC (D). Cells were labeled with CD11b antibodies in addition and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide (PI) fluorescence.

Application imageView details view details

Application imageView details view details

Application imageView details view details

Application imageView details view details
Specifications for CD366 (TIM-3) Antibody, anti-mouse, REAlease®
Overview

Clone REAL168 is an antibody fragment derived from the full CD366 (TIM-3) antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAlease Complex to bind markers with high avidity.

Clone REAL168 recognizes the mouse CD366 (TIM-3) antigen, which is a Tʜ1-specific cell surface protein expressed by differentiated CD4+ Tʜ1 and CD8+ Tc1 cells and macrophages. It is absent on CD4+ Tʜ2 and CD8+ Tc2 cells. CD366 (TIM-3) has been proposed to inhibit Tʜ1-mediated immune responses. TIM-3 absence enhances the severity of experimental autoimmune encephalomyelitis in mice. The interaction of CD366 (TIM-3) and galectin-9 induces apoptosis of Tʜ1 cells.

The REAlease Kits consist of the respective fluorochrome-conjugated REAlease Complexes and the REAlease Support Kit for removal of the REAlease Complexes and optional relabeling with different fluorochrome-conjugated REAlease Complexes.

Alternative names

Tim3, CD366

Detailed product information

Technical specifications

Clone
REAL168
Clonality
monoclonal
Isotype control
Control Antibody
Host
cell line
Type of antibody
Releasable antibodies, Primary antibodies, Recombinant antibodies
Species reactivity
mouse
Antigen
CD366 (TIM-3)
Distribution of antigen
T cells, macrophages, CD4+ T cells, CD8+ T cells
RRID
AB_2784482, AB_2751247
Resources for CD366 (TIM-3) Antibody, anti-mouse, REAlease®
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for CD366 (TIM-3) Antibody, anti-mouse, REAlease®
Publications
  1. van de Weyer, P. S. et al. (2006) A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9. Biochem. Biophys. Res. Commun. 351 (2): 571-576
  2. Monney, L. et al. (2002) Tʜ1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536-541